1. Home
  2. ITRM vs SLAI Comparison

ITRM vs SLAI Comparison

Compare ITRM & SLAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • SLAI
  • Stock Information
  • Founded
  • ITRM 2015
  • SLAI 2001
  • Country
  • ITRM Ireland
  • SLAI United States
  • Employees
  • ITRM N/A
  • SLAI N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • SLAI EDP Services
  • Sector
  • ITRM Health Care
  • SLAI Technology
  • Exchange
  • ITRM Nasdaq
  • SLAI Nasdaq
  • Market Cap
  • ITRM 40.0M
  • SLAI 39.4M
  • IPO Year
  • ITRM 2018
  • SLAI N/A
  • Fundamental
  • Price
  • ITRM $0.48
  • SLAI $1.47
  • Analyst Decision
  • ITRM Strong Buy
  • SLAI
  • Analyst Count
  • ITRM 1
  • SLAI 0
  • Target Price
  • ITRM $9.00
  • SLAI N/A
  • AVG Volume (30 Days)
  • ITRM 1.2M
  • SLAI 135.8K
  • Earning Date
  • ITRM 11-14-2025
  • SLAI 11-21-2025
  • Dividend Yield
  • ITRM N/A
  • SLAI N/A
  • EPS Growth
  • ITRM N/A
  • SLAI N/A
  • EPS
  • ITRM N/A
  • SLAI N/A
  • Revenue
  • ITRM $390,000.00
  • SLAI $24,209,000.00
  • Revenue This Year
  • ITRM N/A
  • SLAI $14.32
  • Revenue Next Year
  • ITRM $482.25
  • SLAI N/A
  • P/E Ratio
  • ITRM N/A
  • SLAI N/A
  • Revenue Growth
  • ITRM N/A
  • SLAI N/A
  • 52 Week Low
  • ITRM $0.36
  • SLAI $1.22
  • 52 Week High
  • ITRM $3.02
  • SLAI $8.07
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 41.91
  • SLAI N/A
  • Support Level
  • ITRM $0.36
  • SLAI N/A
  • Resistance Level
  • ITRM $0.49
  • SLAI N/A
  • Average True Range (ATR)
  • ITRM 0.05
  • SLAI 0.00
  • MACD
  • ITRM -0.00
  • SLAI 0.00
  • Stochastic Oscillator
  • ITRM 43.47
  • SLAI 0.00

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About SLAI SOLAI Limited American Depositary Shares (each representing one hundred (100) Class A Ordinary Shares)

SOLAI Ltd is a cryptocurrency mining company. The company aims to build a comprehensive blockchain-based ecosystem that includes AI, stablecoins, payment infrastructure, and Solana treasury and staking operations.

Share on Social Networks: